148 related articles for article (PubMed ID: 16619218)
21. Zoledronate has an antitumor effect and induces actin rearrangement in dexamethasone-resistant myeloma cells.
Koizumi M; Nakaseko C; Ohwada C; Takeuchi M; Ozawa S; Shimizu N; Cho R; Nishimura M; Saito Y
Eur J Haematol; 2007 Nov; 79(5):382-91. PubMed ID: 17903213
[TBL] [Abstract][Full Text] [Related]
22. Geranylgeranylated proteins are involved in the regulation of myeloma cell growth.
van de Donk NW; Lokhorst HM; Nijhuis EH; Kamphuis MM; Bloem AC
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):429-39. PubMed ID: 15701825
[TBL] [Abstract][Full Text] [Related]
23. Farnesyl transferase inhibitor R115777 induces apoptosis of human myeloma cells.
Le Gouill S; Pellat-Deceunynck C; Harousseau JL; Rapp MJ; Robillard N; Bataille R; Amiot M
Leukemia; 2002 Sep; 16(9):1664-7. PubMed ID: 12200678
[TBL] [Abstract][Full Text] [Related]
24. Nitrogen-containing bisphosphonate mechanism of action.
Reszka AA; Rodan GA
Mini Rev Med Chem; 2004 Sep; 4(7):711-9. PubMed ID: 15379639
[TBL] [Abstract][Full Text] [Related]
25. Fluorescent risedronate analogues reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo.
Roelofs AJ; Coxon FP; Ebetino FH; Lundy MW; Henneman ZJ; Nancollas GH; Sun S; Blazewska KM; Bala JL; Kashemirov BA; Khalid AB; McKenna CE; Rogers MJ
J Bone Miner Res; 2010 Mar; 25(3):606-16. PubMed ID: 20422624
[TBL] [Abstract][Full Text] [Related]
26. In vivo effects of bisphosphonates on the osteoclast mevalonate pathway.
Fisher JE; Rodan GA; Reszka AA
Endocrinology; 2000 Dec; 141(12):4793-6. PubMed ID: 11108295
[TBL] [Abstract][Full Text] [Related]
27. Pamidronate causes apoptosis of plasma cells in vivo in patients with multiple myeloma.
Gordon S; Helfrich MH; Sati HI; Greaves M; Ralston SH; Culligan DJ; Soutar RL; Rogers MJ
Br J Haematol; 2002 Nov; 119(2):475-83. PubMed ID: 12406088
[TBL] [Abstract][Full Text] [Related]
28. YM-175 induces apoptosis of human native monocyte-lineage cells via inhibition of prenylation.
Miwa A; Takezako N; Hayakawa H; Hayakawa M; Tominaga S; Yanagisawa K
Am J Hematol; 2012 Dec; 87(12):1084-8. PubMed ID: 23044853
[TBL] [Abstract][Full Text] [Related]
29. Heterocycle-containing bisphosphonates cause apoptosis and inhibit bone resorption by preventing protein prenylation: evidence from structure-activity relationships in J774 macrophages.
Luckman SP; Coxon FP; Ebetino FH; Russell RG; Rogers MJ
J Bone Miner Res; 1998 Nov; 13(11):1668-78. PubMed ID: 9797474
[TBL] [Abstract][Full Text] [Related]
30. Mechanisms for autophagy modulation by isoprenoid biosynthetic pathway inhibitors in multiple myeloma cells.
Dykstra KM; Allen C; Born EJ; Tong H; Holstein SA
Oncotarget; 2015 Dec; 6(39):41535-49. PubMed ID: 26595805
[TBL] [Abstract][Full Text] [Related]
31. Pamidronate, farnesyl transferase, and geranylgeranyl transferase-I inhibitors affects cell proliferation, apoptosis, and OPG/RANKL mRNA expression in stromal cells of giant cell tumor of bone.
Lau CP; Huang L; Tsui SK; Ng PK; Leung PY; Kumta SM
J Orthop Res; 2011 Mar; 29(3):403-13. PubMed ID: 20886653
[TBL] [Abstract][Full Text] [Related]
32. A highly sensitive prenylation assay reveals in vivo effects of bisphosphonate drug on the Rab prenylome of macrophages outside the skeleton.
Ali N; Jurczyluk J; Shay G; Tnimov Z; Alexandrov K; Munoz MA; Skinner OP; Pavlos NJ; Rogers MJ
Small GTPases; 2015 Oct; 6(4):202-11. PubMed ID: 26399387
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels.
van de Donk NW; Kamphuis MM; van Kessel B; Lokhorst HM; Bloem AC
Blood; 2003 Nov; 102(9):3354-62. PubMed ID: 12855556
[TBL] [Abstract][Full Text] [Related]
34. Zoledronic acid treatment impairs protein geranyl-geranylation for biological effects in prostatic cells.
Goffinet M; Thoulouzan M; Pradines A; Lajoie-Mazenc I; Weinbaum C; Faye JC; Séronie-Vivien S
BMC Cancer; 2006 Mar; 6():60. PubMed ID: 16539721
[TBL] [Abstract][Full Text] [Related]
35. Structure-activity relationships for inhibition of farnesyl diphosphate synthase in vitro and inhibition of bone resorption in vivo by nitrogen-containing bisphosphonates.
Dunford JE; Thompson K; Coxon FP; Luckman SP; Hahn FM; Poulter CD; Ebetino FH; Rogers MJ
J Pharmacol Exp Ther; 2001 Feb; 296(2):235-42. PubMed ID: 11160603
[TBL] [Abstract][Full Text] [Related]
36. Bisphosphonates act directly on the osteoclast to induce caspase cleavage of mst1 kinase during apoptosis. A link between inhibition of the mevalonate pathway and regulation of an apoptosis-promoting kinase.
Reszka AA; Halasy-Nagy JM; Masarachia PJ; Rodan GA
J Biol Chem; 1999 Dec; 274(49):34967-73. PubMed ID: 10574973
[TBL] [Abstract][Full Text] [Related]
37. Inhibition of Rab prenylation by statins induces cellular glycosphingolipid remodeling.
Binnington B; Nguyen L; Kamani M; Hossain D; Marks DL; Budani M; Lingwood CA
Glycobiology; 2016 Feb; 26(2):166-80. PubMed ID: 26405105
[TBL] [Abstract][Full Text] [Related]
38. N-Oxide derivatives of 3-(3-pyridyl)-2-phosphonopropanoic acids as potential inhibitors of Rab geranylgeranylation.
Zhou X; Born EJ; Allen C; Holstein SA; Wiemer DF
Bioorg Med Chem Lett; 2015 Jun; 25(11):2331-4. PubMed ID: 25935643
[TBL] [Abstract][Full Text] [Related]
39. Protein geranylgeranylation is required for osteoclast formation, function, and survival: inhibition by bisphosphonates and GGTI-298.
Coxon FP; Helfrich MH; Van't Hof R; Sebti S; Ralston SH; Hamilton A; Rogers MJ
J Bone Miner Res; 2000 Aug; 15(8):1467-76. PubMed ID: 10934645
[TBL] [Abstract][Full Text] [Related]
40. Statins induce apoptosis in rat and human myotube cultures by inhibiting protein geranylgeranylation but not ubiquinone.
Johnson TE; Zhang X; Bleicher KB; Dysart G; Loughlin AF; Schaefer WH; Umbenhauer DR
Toxicol Appl Pharmacol; 2004 Nov; 200(3):237-50. PubMed ID: 15504460
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
